Ligand-dependent linkage of the ATP site to inhibition gate closure in the KATP channel.
Major advances have been made on the inhibition gate and ATP site of the K(ir)6.2 subunit of the K(ATP) channel, but little is known about conformational coupling between the two. ATP site mutations dramatically disrupt ATP-dependent gating without effect on ligand-independent gating, observed as interconversions between active burst and inactive interburst conformations in the absence of ATP. This suggests that linkage between site and gate is conditionally dependent on ATP occupancy. We studied all substitutions at position 334 of the ATP site in K(ir)6.2deltaC26 that express in Xenopus oocytes. All substitutions disrupted ATP-dependent gating by 10-fold or more. Only positive-charged arginine or lysine at 334, however, slowed ligand-independent gating from the burst, and this was in some but not all patches. Moreover, the polycationic peptide protamine reversed the slowed gating from the burst of 334R mutant channels, and speeded the slow gating from the burst of wild-type SUR1/K(ir)6.2 in the absence of ATP. Our results support a two-step ligand-dependent linkage mechanism for K(ir)6.2 channels in which ATP-occupied sites function to electrostatically dissociate COOH-terminal domains from the membrane, then as in all K(ir) channels, free COOH-terminal domains and inner M2 helices transit to a lower energy state for gate closure.
Li
Lehong
L
Department of Cell Biology and Physiology, University of Pittsburgh School of Medicine, PA 15261, USA.
Geng
Xuehui
X
Yonkunas
Michael
M
Su
Anjey
A
Densmore
Erik
E
Tang
Pei
P
Drain
Peter
P
D000255:Adenosine Triphosphate / Q000494:pharmacology*; D019943:Amino Acid Substitution; D000818:Animals; D001120:Arginine / Q000737:chemistry; D001665:Binding Sites / Q000187:drug effects; D002478:Cells, Cultured; D003001:Cloning, Molecular; D004305:Dose-Response Relationship, Drug; D015640:Ion Channel Gating / Q000187:drug effects / Q000502:physiology; D008239:Lysine / Q000737:chemistry; D008564:Membrane Potentials / Q000187:drug effects; D008958:Models, Molecular; D009865:Oocytes / Q000378:metabolism; D024661:Potassium Channels, Inwardly Rectifying / Q000737:chemistry* / Q000187:drug effects / Q000378:metabolism*; D011479:Protamines / Q000494:pharmacology; D017434:Protein Structure, Tertiary; D021122:Protein Subunits / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism; D014982:Xenopus laevis; D000099161:Kcnj11 Channel
D000255:Adenosine Triphosphate; D001120:Arginine; D008239:Lysine; D024661:Potassium Channels, Inwardly Rectifying; D011479:Protamines; D021122:Protein Subunits; D000099161:Kcnj11 Channel